Does CATEQUENTINIB Cause Product use in unapproved indication? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Product use in unapproved indication have been filed in association with CATEQUENTINIB. This represents 4.9% of all adverse event reports for CATEQUENTINIB.
16
Reports of Product use in unapproved indication with CATEQUENTINIB
4.9%
of all CATEQUENTINIB reports
3
Deaths
8
Hospitalizations
How Dangerous Is Product use in unapproved indication From CATEQUENTINIB?
Of the 16 reports, 3 (18.8%) resulted in death, 8 (50.0%) required hospitalization, and 2 (12.5%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CATEQUENTINIB. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does CATEQUENTINIB Cause?
Myelosuppression (84)
Off label use (37)
Diarrhoea (33)
Hypertension (26)
Nausea (26)
Vomiting (26)
Rash (25)
Thrombocytopenia (24)
Fatigue (23)
Anaemia (22)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which CATEQUENTINIB Alternatives Have Lower Product use in unapproved indication Risk?
CATEQUENTINIB vs CC-4047
CATEQUENTINIB vs CEDAZURIDINE\DECITABINE
CATEQUENTINIB vs CEDIRANIB
CATEQUENTINIB vs CEFACLOR
CATEQUENTINIB vs CEFADROXIL